Genomes2People

Genomes2People (G2P) is a research program based at Mass General Brigham, Broad Institute, Ariadne Labs, and Harvard Medical School that conducts research on translational genomics, precision medicine, and health outcomes.[1] The program investigates the medical, behavioral, and economic impacts of integrating genomic information for adults and children into clinical care and public health.[2][3]

Founded by Robert C. Green in 2011, G2P has received over $70 million from the National Institutes of Health (NIH) and other partners[4] to support multiple large-scale studies and clinical trials.[5][6]

References

  1. ↑ "Genomes2People – Research In Translational Genomics and Health Outcomes". Retrieved 2026-05-14.
  2. ↑ "Keynote Presentation: The Path to Universal Newborn Sequencing". Labroots. Retrieved 2026-05-14.
  3. ↑ "Screening study brings Sanford Health, Harvard together". Sanford Health News. Retrieved 2026-05-14.
  4. ↑ Borrelli-Persson, Laird (2020-12-22). "Franca Sozzani Has Inspired a Scientific Fund—And Now a Website". Vogue. Retrieved 2026-05-14.
  5. ↑ Labs, Ariadne. "Ariadne Labs and Genomes2People Launch New Precision Population Health Initiative". www.prnewswire.com. Retrieved 2026-05-14.
  6. ↑ Wolf, Susan M.; Green, Robert C. (2023-08-25). "Return of Results in Genomic Research Using Large-Scale or Whole Genome Sequencing: Toward a New Normal". Annual Review of Genomics and Human Genetics. 24: 393–414. doi:10.1146/annurev-genom-101122-103209. ISSN 1545-293X. PMC 10497726. PMID 36913714.
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.